- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | Archrock Reports Fourth Quarter and Full Year 2025 Results and Provides 2026 Financial Guidance | ||
| Di | HP Inc. Reports Fiscal 2026 First Quarter Results | ||
| Di | Standard BioTools Inc.: Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results | ||
| Di | Werewolf Therapeutics, Inc.: Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives | ||
| Di | Valley National Bank: Valley National Bancorp Announces Adoption of Share Repurchase Program | ||
| Di | SPX Technologies: SPX Reports Fourth Quarter and Full-Year 2025 Results | ||
| Di | Carlyle Secured Lending, Inc. Announces Financial Results For Fourth Quarter and Full Year Ended December 31, 2025, Declares First Quarter 2026 Dividend of $0.40 Per Common Share | ||
| Di | Serina Therapeutics, Inc.: Serina Therapeutics Announces Dosing of First Patient in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease | ||
| Di | Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results | ||
| Di | CCC Intelligent Solutions Holdings Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results | ||
| Di | ABM Industries Incorporated: ABM to Announce First Quarter 2026 Financial Results | ||
| Di | Vaxcyte, Inc.: Vaxcyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update | ||
| Di | Valley National Bank: Valley National Bancorp Declares Its Regular Quarterly Preferred and Common Stock Dividends | ||
| Di | Flywire Corporation: Flywire Reports Fourth Quarter and Fiscal-Year 2025 Financial Results | ||
| Di | Micron Technology, Inc.: Micron Technology to Report Fiscal Second Quarter Results on March 18, 2026 | ||
| Di | BridgeBio Pharma, Inc.: BridgeBio Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial Updates | ||
| Di | Bicara Therapeutics Inc.: Bicara Therapeutics Announces Proposed Public Offering of Common Stock | ||
| Di | EXL Reports 2025 Fourth Quarter and Year-End Results; Issues 2026 Guidance | ||
| Di | SLR Investment Corp. Announces Quarter and Year Ended December 31, 2025 Financial Results | ||
| Di | RF Acquisition Corp III Announces the Separate Trading of its Ordinary Shares and Rights Commencing February 26, 2026 | ||
| Di | Day One Biopharmaceuticals, Inc.: Day One Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Outlook and Revenue Guidance | ||
| Di | Cytokinetics, Incorporated: Cytokinetics Reports Fourth Quarter 2025 Financial Results and Provides Business Update | ||
| Di | Trifork Group AG: 11/2026·Trifork Group: Change of reporting segmentation | ||
| Di | SPACSphere Acquisition Corp. Announces the Separate Trading of Its Class A Ordinary Shares, Warrants, and Rights, Commencing on or About February 27, 2026 | ||
| Di | Genmab A/S: Capital Increase in Genmab as a Result of Employee Warrant Exercise |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.